Posts
April 25 2025
Texas Ventures Acquisition III Corp announced the closing of its initial public offering in the amount of $225,000,000. EGS acted as counsel to Texas Ventures Acquisition III Corp.
April 25 2025
ReTo Eco-Solutions, Inc. announced the closing of its acquisition of 51% of the equity interests of MeinMalzeBier Holdings Limited, a company engaged in the marketing and sales of craft beer and craft beer machines in China, for aggregate consideration of $19,890,000. EGS acted as counsel to ReTo Eco-Solutions, Inc.
April 23 2025
Cantor Equity Partners, Inc. announced the signing of its definitive business combination agreement with Twenty One Capital, Inc., a Bitcoin-native company with a pro-forma enterprise value of $3.6 billion. EGS acted as counsel to Cantor Equity Partners, Inc.
April 22 2025
Valerie Bluth, a member of the Firm, wrote an article for Total Food Service titled: “Protecting Your Hospitality Business as Threat of ICE Raids Persists.” In the article, Valerie offers practical strategies to hospitality operators to safeguard their business and their employees in light of ongoing federal immigration enforcement efforts, emphasizing the importance of employee training, proactive measures, and legal compliance.
Click here to read the article.
April 22 2025
Aptevo Therapeutics Inc. announced the closing of its Registered Direct Offering in the amount of $2,000,000. EG&S acted as counsel to the Placement Agent.
April 21 2025
Client Alert: U.S. Citizenship and Immigration Services Issues New Form I-9 For Employment Eligibility Verification
U.S. Citizenship and Immigration Services (USCIS) issued a new version of its Form I-9 on January 20, 2025, which has a May 31, 2027 expiration date. Although previous versions of the Form I-9 remain valid until their stated expiration dates, employers should immediately begin using this new version for all new hires, re-hires, and re-verifications.
Click here to read the alert.
April 21 2025
NioCorp Developments Ltd. announced the closing of its Underwritten Public Offering in the amount of $20,000,000. EG&S acted as counsel to the Underwriter.
April 15 2025
Can-Fite Biopharma Ltd. announced the closing of its Registered Direct Offering in the amount of $3,000,000. EG&S acted as counsel to the Placement Agent.